|
Etoposide Phosphate Clinical Trials
6 actively recruiting trials across 3 locations
No change since May 2026
Also known as: Etopophos, VePesid
Pipeline
Early 1: 1Phase 2: 2Phase 3: 2Phase 2/3: 1
Top Sponsors
- University of Birmingham1
- National Cancer Institute (NCI)1
- Medical University of Vienna1
- Joseph Tuscano1
- Children's Oncology Group1
Indications
- Cancer6
- Neuroblastoma2
- Rare CNS Tumor Recurrent1
- Refractory Nodal Marginal Zone Lymphoma1
- Refractory High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements1
Other2 trials
Birmingham, Alabama2 trials
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Children's Hospital of Alabama
Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Children's Hospital of Alabama
Phase 3
Sacramento, California1 trial
Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
University of California Davis Comprehensive Cancer Center
Phase 2
Chicago, Illinois1 trial
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Ann & Robert H. Lurie Children's Hospital of Chicago
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.